Jordan M. Engelhardt is a partner in the firm’s Litigation practice, with experience representing organizations and individuals in commercial litigation and intellectual property matters across a range of industries, including commercial real estate, financial services, healthcare, and technology. His commercial real estate clients include investors, landlords, and developers. In addition, he has handled high-stakes disputes for major pharmaceutical and medical device companies, financial institutions, and high net worth individuals.

A skilled and versatile attorney, Jordan has experience in federal and state courts, administrative agency matters, alternative dispute resolution, and strategic client counseling. He is also well versed in emergency court procedures, having secured expedited relief for both businesses and individuals in their most pressing and sensitive matters.

Jordan has written extensively on commercial litigation and intellectual property issues. His work has been featured in widely distributed legal and industry publications, such as New York Law Journal, Law360, Bloomberg Law, Commercial Observer, and Intellectual Property Magazine. Jordan has also co-authored several amicus briefs in cases before the United States Supreme Court.

Representative Matters

Commercial Real Estate

• Representing major real estate investor in litigation to redress violations of rights across multiple New York City properties
• Serving as lead counsel on behalf of commercial landlord in high-stakes dispute over warehouse tenant’s improper attempts to exercise purchase option
• Defended real estate development company against financer’s unauthorized use of confidential information to threaten interference with purchase transaction

Corporate Governance

• Advising managing member of multiple real estate holding companies concerning rights and remedies under LLC operating agreements and principles of fiduciary duties
• Directed activism campaign by hedge fund as shareholder in publicly traded REIT by demanding board of directors fulfill fiduciary duties by terminating insider agreement
• Successfully represented closely held commercial real estate company against challenge by minority shareholder, leading to the case’s dismissal

Financial Services Litigation

• Successfully litigated sophisticated breach-of-contract and fraud actions against sponsors and underwriters of residential mortgage-backed securitizations, securing over $1 billion in recoveries for financial guaranty insurer clients
• Vigorously pursued remedies available to hedge fund as investor in mortgage servicer advance receivables trust following events of default, leading to favorable settlement

Intellectual Property

• Representing leading audiology equipment company in litigation to redress theft of trade secrets and unfair competition
• Litigated successful patent infringement action to enforce IP rights and prevent competitor’s infringement, leading to favorable settlement for leading LED lighting company
• Provided trademark counseling to real estate developer concerned with competitor’s use of similar mark in the residential leasing market
• Successfully resolved multiple patent infringement litigations involving breakthrough medical treatments on behalf of innovator pharmaceutical companies, teaming with outside experts and business leaders

Professional Activities

• New York City Bar Association, Real Property Law Committee (2022-25 term)

In the Media

• Co-author, “Force Majeure in 2022: What to Know for Commercial Leases,” Commercial Observer (December 8, 2021)
• Co-author, “New York Commercial Division Practice Guide, Chapter III: Rules of the Commercial Division,” Bloomberg (2019 edition)
• Co-author, “Federal Circuit Strikes Down Diagnostic Patent in Latest § 101 Decision,” IP Litigator, Volume 25, Number 2 (March/April 2019)
• Co-author, “PTAB and Bar Prepare for Aftermath of Supreme Court’s SAS Decision,” IP Litigator, Volume 24, Number 4 (July/August 2018)
• Co-author, “Beyond the Presumption Against Extraterritoriality,” Intellectual Property Magazine (August 22, 2018)
• Co-author, “Fed. Circ. Case May Change Biosimilar IPR Strategy,” Law360 (April 2018)
• Co-author, “First, Second Departments Split on What Is Considered ‘Documentary Evidence’,” New York Law Journal (December 2017)
• Co-author, “Long-Arm Jurisdiction in a Post-Daimler Era,” Law360 (January 2017)

Presentations

• CLE Presenter, “Litigation Nut & Bolts: Pleadings in Federal and State Court” (Feb. 2021)
• Speaker, “Working with Expert Witnesses,” Fordham University School of Law, Commercial Litigation course (Fall 2019)
• CLE Presenter, The Legal Aid Society Bronx Juvenile Rights Practice Deposition Training (June 2016)
• Panel Member, “The Financial Reporting and Audit Task Force – The SEC Goes Back to the Future,” New York City Bar Association (April 2016)